Skip to main content
SpringerLink
Log in

Specific expression of ZO-1 and N-cadherin in rosette structures of various tumors: possible recapitulation of neural tube formation in embryogenesis and utility as a potentially novel immunohistochemical marker of rosette formation in pulmonary neuroendocrine tumors

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Neuroendocrine tumors can develop in various organs. All of these tumors are designated on the basis of their morphologic characteristics evident by light microscopy, and by immunohistochemistry for antigens such as synaptophysin, chromogranin-A, and CD56/NCAM. In the present study, we attempted to demonstrate the localization of Zonula occludens-1 (ZO-1) and N-cadherin in rosette structures of neuroendocrine tumors using immunohistochemistry and to clarify their specific distribution in rosettes in human pulmonary neuroendocrine tumors in comparison with various types of adenocarcinoma. Among 40 neuroendocrine tumors of the lung examined, 18 cases (45%) and 22 cases (55%) were positive for ZO-1 and N-cadherin, respectively. In addition, we divided the cases into two types: 16 cases of Flexner-type tumor and 24 cases of Homer–Wright-type tumor. We then determined the Rosette Index (RoI; the percentage fraction of rosette structures positive for ZO-1 or N-cadherin among the total number of rosette structures). The Flexner-type neuroendocrine tumors showed significantly higher levels of RoI in ZO-1 than the Homer–Wright-type neuroendocrine tumors (median; 38.8% vs 0%, p < 0.001). On the other hand, N-cadherin and ZO-1 were hardly detected in tubular adenocarcinomas in various organs, and their immunoreactivities differed significantly between adenocarcinoma and pulmonary neuroendocrine tumor (ZO-1, mean 0.23% vs 18%, p < 0.0001; N-cadherin, mean 0% vs 33%, p < 0.0001). In conclusion, expression of ZO-1 and N-cadherin may reflect the mechanisms leading to rosette formation in neuroendocrine tumors, which possibly recapitulate neural tube formation in embryogenesis and could represent a specific immunohistochemical marker for neuroendocrine carcinoma of the lung.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Colby TV KM, Travis WD. Large cell neuroendocrine carcinoma:, In: Colby TV KM, Travis WD, editors (1995) Tumors of the lower respiratory tract. Armed Forces Institute of Pathology:248–257

  2. Travis WD BE, Müller-Hermelink HK, Harris CC editor (2004) Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. World Health Organization Classification of Tumours 10

  3. Arrigoni MG, Woolner LB, Bernatz PE (1972) Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 64(3):413–421

    PubMed  CAS  Google Scholar 

  4. Carretta A, Ceresoli GL, Arrigoni G, Canneto B, Reni M, Cigala C, Zannini P (2000) Diagnostic and therapeutic management of neuroendocrine lung tumors: a clinical study of 44 cases. Lung Cancer 29(3):217–225

    Article  PubMed  CAS  Google Scholar 

  5. Garcia-Yuste M, Matilla JM, Alvarez-Gago T, Duque JL, Heras F, Cerezal LJ, Ramos G (2000) Prognostic factors in neuroendocrine lung tumors: a Spanish Multicenter Study. Spanish Multicenter Study of Neuroendocrine Tumors of the Lung of the Spanish Society of Pneumonology and Thoracic Surgery (EMETNE-SEPAR). Ann Thorac Surg 70(1):258–263

    Article  PubMed  CAS  Google Scholar 

  6. Gould VE, Linnoila RI, Memoli VA, Warren WH (1983) Neuroendocrine cells and neuroendocrine neoplasms of the lung. Pathol Annu 18(Pt 1):287–330

    PubMed  Google Scholar 

  7. Jiang SX, Kameya T, Shoji M, Dobashi Y, Shinada J, Yoshimura H (1998) Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases. Am J Surg Pathol 22(5):526–537

    Article  PubMed  CAS  Google Scholar 

  8. Naranjo Gomez JM, Gomez Roman JJ Behaviour and survival of high-grade neuroendocrine carcinomas of the lung. Respir Med 104 (12):1929–1936

  9. Peng WX, Sano T, Oyama T, Kawashima O, Nakajima T (2005) Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinoma. Lung Cancer 47(2):225–233

    Article  PubMed  Google Scholar 

  10. Takei H, Asamura H, Maeshima A, Suzuki K, Kondo H, Niki T, Yamada T, Tsuchiya R, Matsuno Y (2002) Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg 124(2):285–292

    Article  PubMed  Google Scholar 

  11. Warren WH, Faber LP, Gould VE (1989) Neuroendocrine neoplasms of the lung. A clinicopathologic update. J Thorac Cardiovasc Surg 98(3):321–332

    PubMed  CAS  Google Scholar 

  12. Warren WH, Gould VE, Faber LP, Kittle CF, Memoli VA (1985) Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervening variants. J Thorac Cardiovasc Surg 89(6):819–825

    PubMed  CAS  Google Scholar 

  13. Warren WH, Memoli VA, Gould VE (1988) Well differentiated and small cell neuroendocrine carcinomas of the lung. Two related but distinct clinicopathologic entities. Virchows Arch B Cell Pathol Incl Mol Pathol 55(5):299–310

    PubMed  CAS  Google Scholar 

  14. Kloppel G (2007) Tumour biology and histopathology of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 21(1):15–31

    Article  PubMed  Google Scholar 

  15. Wippold FJ 2nd, Perry A (2006) Neuropathology for the neuroradiologist: rosettes and pseudorosettes. AJNR Am J Neuroradiol 27(3):488–492

    PubMed  Google Scholar 

  16. Koch P, Opitz T, Steinbeck JA, Ladewig J, Brustle O (2009) A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration. Proc Natl Acad Sci U S A 106(9):3225–3230

    Article  PubMed  CAS  Google Scholar 

  17. Elkabetz Y, Panagiotakos G, Al Shamy G, Socci ND, Tabar V, Studer L (2008) Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev 22(2):152–165

    Article  PubMed  CAS  Google Scholar 

  18. Aaku-Saraste E, Hellwig A, Huttner WB (1996) Loss of occludin and functional tight junctions, but not ZO-1, during neural tube closure–remodeling of the neuroepithelium prior to neurogenesis. Dev Biol 180(2):664–679

    Article  PubMed  CAS  Google Scholar 

  19. Nishimura T, Takeichi M (2008) Shroom3-mediated recruitment of Rho kinases to the apical cell junctions regulates epithelial and neuroepithelial planar remodeling. Development 135(8):1493–1502

    Article  PubMed  CAS  Google Scholar 

  20. Hatta K, Takeichi M (1986) Expression of N-cadherin adhesion molecules associated with early morphogenetic events in chick development. Nature 320(6061):447–449

    Article  PubMed  CAS  Google Scholar 

  21. Hatta K, Takagi S, Fujisawa H, Takeichi M (1987) Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos. Dev Biol 120(1):215–227

    Article  PubMed  CAS  Google Scholar 

  22. Zynger DL, Dimov ND, Ho LC, Laskin WB, Yeldandi AV (2008) Differential expression of neural-cadherin in pulmonary epithelial tumours. Histopathology 52(3):348–354

    Article  PubMed  CAS  Google Scholar 

  23. Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA (1986) Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol 103(3):755–766

    Article  PubMed  CAS  Google Scholar 

  24. Itoh M, Nagafuchi A, Yonemura S, Kitani-Yasuda T, Tsukita S, Tsukita S (1993) The 220-kD protein colocalizing with cadherins in non-epithelial cells is identical to ZO-1, a tight junction-associated protein in epithelial cells: cDNA cloning and immunoelectron microscopy. J Cell Biol 121(3):491–502

    Article  PubMed  CAS  Google Scholar 

  25. Tsukita S, Yamazaki Y, Katsuno T, Tamura A, Tsukita S (2008) Tight junction-based epithelial microenvironment and cell proliferation. Oncogene 27(55):6930–6938

    Article  PubMed  CAS  Google Scholar 

  26. Katsuno T, Umeda K, Matsui T, Hata M, Tamura A, Itoh M, Takeuchi K, Fujimori T, Nabeshima Y, Noda T, Tsukita S, Tsukita S (2008) Deficiency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cells. Mol Biol Cell 19(6):2465–2475

    Article  PubMed  CAS  Google Scholar 

  27. Palatinus JA, O'Quinn MP, Barker RJ, Harris BS, Jourdan J, Gourdie RG ZO-1 determines adherens and gap junction localization at intercalated disks. Am J Physiol Heart Circ Physiol 300 (2):H583-594

  28. Smalley KS, Brafford P, Haass NK, Brandner JM, Brown E, Herlyn M (2005) Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. Am J Pathol 166(5):1541–1554

    Article  PubMed  CAS  Google Scholar 

  29. Wang Y, Zhou J, Zeng F, Huang Y, Zhou S, Liu X [Expression and clinical significance of ZO-1 in patients with non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi 14 (2):146–150

  30. Ohtani S, Terashima M, Satoh J, Soeta N, Saze Z, Kashimura S, Ohsuka F, Hoshino Y, Kogure M, Gotoh M (2009) Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival. Gastric Cancer 12(1):43–51

    Article  PubMed  CAS  Google Scholar 

  31. Asamura H, Kameya T, Matsuno Y, Noguchi M, Tada H, Ishikawa Y, Yokose T, Jiang SX, Inoue T, Nakagawa K, Tajima K, Nagai K (2006) Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 24(1):70–76

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

We declare that we have no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Diagnostic Pathology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki, 305-8575, Japan

    Kaishi Satomi, Yukio Morishita, Shingo Sakashita, Yuko Minami & Masayuki Noguchi

  2. Department of Pathology, Tsukuba University Hospital, 2-1-1 Amakubo, Tsukuba-shi, Ibaraki, 305-8576, Japan

    Yuzuru Kondou & Shuichiroh Furuya

Authors
  1. Kaishi Satomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yukio Morishita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shingo Sakashita
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuzuru Kondou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shuichiroh Furuya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuko Minami
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masayuki Noguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masayuki Noguchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Satomi, K., Morishita, Y., Sakashita, S. et al. Specific expression of ZO-1 and N-cadherin in rosette structures of various tumors: possible recapitulation of neural tube formation in embryogenesis and utility as a potentially novel immunohistochemical marker of rosette formation in pulmonary neuroendocrine tumors. Virchows Arch 459, 399–407 (2011). https://doi.org/10.1007/s00428-011-1120-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-011-1120-z

Keywords

Search

Navigation